LivaNova (LIVN) Cash from Restructuring (2016 - 2020)
LivaNova's (LIVN) quarterly Cash from Restructuring came in at -$277000.0 in Q3 2020, up 78.58% year-on-year from -$155115.2 in Q4 2019, and up 41.56% quarter-over-quarter from -$474000.0 in Q2 2020.
LivaNova (LIVN) Cash from Restructuring (2016 - 2020) Analysis & Trends
LivaNova has disclosed Cash from Restructuring across 5 years of filings, most recently posting -$277000.0 for Q3 2020.
- Cash from Restructuring for Q3 2020 came in at -$277000.0, up 78.58% year-over-year; the trailing twelve-month figure through Sep 2020 was -$1.2 million (down 86.51% YoY), and the FY2019 annual result was -$6.7 million, down 203.74% from the prior year.
- Cash from Restructuring came in at -$277000.0 for Q3 2020 at LivaNova, up from -$474000.0 in the prior quarter.
- In the past five years, Cash from Restructuring ranged from a high of $22.0 million in Q1 2016 to a low of -$6.7 million in Q1 2017.
- The 5-year median for Cash from Restructuring is -$594000.0 (2018), against an average of $89944.4.
- Across the five-year window, Cash from Restructuring soared 440.13% in 2018 and slumped 1639.29% in 2019, its largest moves.
- LivaNova's Cash from Restructuring stood at -$2.6 million in 2016, then climbed by 29.42% to -$1.8 million in 2017, then jumped by 440.13% to $6.1 million in 2018, then slumped by 99.69% to $19000.0 in 2019, then slumped by 1557.89% to -$277000.0 in 2020.
- The last three Cash from Restructuring figures came in at -$277000.0 (Q3 2020), -$474000.0 (Q2 2020), and -$443000.0 (Q1 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | LivaNova | 4.29 Bn | 3.71 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -277,000.00 |
| Jun 30, 2020 | -474,000.00 |
| Mar 31, 2020 | -443,000.00 |
| Dec 31, 2019 | 19,000.00 |
| Sep 30, 2019 | -1.29 Mn |
| Jun 30, 2019 | -567,000.00 |
| Mar 31, 2019 | -4.91 Mn |
| Dec 31, 2018 | 6.14 Mn |
| Sep 30, 2018 | 84,000.00 |
| Jun 30, 2018 | -621,000.00 |
| Mar 31, 2018 | 905,000.00 |
| Dec 31, 2017 | -1.80 Mn |
| Sep 30, 2017 | -1.62 Mn |
| Jun 30, 2017 | -4.43 Mn |
| Mar 31, 2017 | -6.70 Mn |
| Dec 31, 2016 | -2.56 Mn |
| Sep 30, 2016 | -1.84 Mn |
| Mar 31, 2016 | 22.01 Mn |